Dinney CPN, Narayan VM. Reply: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With
Bacillus Calmette-Guerin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year
Follow-Up From a Phase 3 Trial. J Urol 2024 Jul 5:101097JU0000000000004128. doi: 10.1097/JU.0000000000004128.
PMID: 38968037
![]() |
![]() |
![]() |